drugset / Trial / NCT00228982
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to compare the clinical cure rate of ceftobiprole medocaril versus a comparator in the treatment of patients with complicated skin and skin structure infections.
Timeline
- Start
- 2004-10
- Primary completion
- 2005-12
- Completion
- 2005-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ceftobiprole medocaril | Small molecule | 500 mg | — |
| Comparator | Vancomycin | Other / unclassified | 1 g | — |